Skip to content
Frontiers
Search

Correction

Frontiers in Antibiotics ·

Volume 5 - 2026 | https://doi.org/10.3389/frabi.2026.1804100

Correction: Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance

  • Paulina Topa-Pila1
  • Katheryne Y. Morales1
  • Doménica P. Palacios-Mora2
  • Cristina Flores-Hernández3
  • Analía Altamirano-Cisneros1
  • Joselyn Micaela Gavilanes1
  • Keyla Villacís-López1
  • Mirari Arancibia1
  • Johanna Mora-Domínguez4
  • William Calero-Cáceres1,5*corresponding author
  1. 1Biotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador
  2. 2Clínica Santa Ana, Cuenca, Ecuador
  3. 3Departamento de Ciencias Exactas Sede Latacunga, Universidad de las Fuerzas Armadas ESPE, Rumiñahui, Ecuador
  4. 4Hospital de Especialidades José Carrasco Arteaga, Instituto Ecuatoriano de Seguridad Social (IESS), Cuenca, Ecuador
  5. 5UTA-RAM-One Health, Group for Universal Advance in Bioscience, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador
Article metrics0 viewsView details
PDFCiteMetrics

Abstract

Keywords

Author Analía Altamirano-Cisneros was erroneously spelled as AnalÃŁa Altamirano. The Author contributions statement, citation and copyright have been corrected accordingly.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Citation

Topa-Pila, P., et al. (2026). Correction: Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance. Frontiers in Antibiotics, Volume 5. https://doi.org/
Received
Accepted
Published
Volume
5 - 2026

Copyright

Copyright © 2026 Topa-Pila, Morales, Palacios-Mora, Flores-Hernández, Altamirano-Cisneros, Gavilanes, Villacís-López, Arancibia, Mora-Domínguez and Calero-Cáceres.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: William Calero-Cáceres

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0

Related articles

PerspectiveCeftriaxone-by-default in surgical prophylaxis across the East African community: a measurement problemSamar Rashid Abdullahi, Nathan Mugenyi, Lucy Ochola, Jamal Abade Mohamed, Hussein Iman Sigat, Abdirizak Ali Yusuf, Wigilya P. Mikomangwa, Armstrong Ndihokubwayo, David Majuch Kunjok, Schifra Uwamungu, Nathan Banzi, Barbra TuhamizeOpinionWhether, or under what conditions? A configurational approach to AI-supported antimicrobial stewardship in sub-Saharan AfricaAbdulrasheed IbrahimOriginal ResearchGenomic insights into multidrug and extensively drug-resistant Klebsiella pneumoniae from bloodstream infections at three Zambian tertiary hospitalsJoseph Yamweka Chizimu, Harvey Kakoma Kamboyi, Maisa Kasanga, Taona Sinyawa, Misheck Shawa, Ruth Nakazwe, Steward Mudenda, Joseph Njung’e, Susan Kiiru, Mungunsar Chuluun, Chileshe Lukwesa, Zoran Muhimba, Victor Daka, Dianah Tibatemwa, Everlyn Wesangula, O-Tipo Shikanga, Sandra Diana Mwadetsa, Nchimunya Machila, Veronica Chuchu, Zachariah Mupila, Peter Clement Lasuba, Yasuhiko Suzuki, Flavien Nsoni Bumbangi, Roma Chilengi